| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a8e7ebe142a716ec8d0685edb5f205a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-302
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-602
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45df497fc96fd127119d7c9009fdedbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0fadbfccc32b05570002678ace60a32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33ad14017f417d96d11d6892b07d06b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b5340e530257c394de042a3460adb95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72fe4e23829a61f992f1d72d582e410b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22c2bc22f7120d505010f6e2090d33ff |
| publicationDate |
2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11090324-B2 |
| titleOfInvention |
Composition, for remedying female climacteric syndrome symptoms, comprising tectorigenin 7-O-Xylosylglucoside |
| abstract |
The present disclosure relates to a composition for preventing, treating or remedying female climacteric syndrome symptoms, which contains tectorigenin 7-O-xylosylglucoside. The composition according to the present disclosure shows quick effects for preventing, remedying and/or treating female climacteric syndrome symptoms, particularly facial flushing and/or osteoporosis, and thus can be utilized for the hormone replacement therapy (HRT) used for preventing or remedying climacteric syndrome symptoms. |
| priorityDate |
2017-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |